Oncology Events Calendar
Discover conferences, symposia and other events worldwide.
View monthly calendar
Submit your event
233 event(s) found
TTLC 2026
TTLC 2026 organized by IASLC
18/02/2026 - 21/02/2026
Hybrid
IASLC
Huntington Beach, CA, United States
TBD Myeloid Cells: Functional Heterogeneity with Therapeutic Promise
This Keystone Myeloid Cell meeting aims to bring together key leaders in academia and industry to discuss recent insights regarding myeloid cell functional heterogeneity and how to target these cells for therapeutic interventions. It is clear that myeloid cells hold significant therapeutic promise, but this potential is yet to be realized. While previous meetings have typically focused on academic advances, this meeting will also cover the latest industry approaches and novel therapeutic applications. By bringing together all actors we will stimulate discussions and collaboration that will drive translational advances and more rapidly realize transformative applications in the field.
23/02/2026 - 26/02/2026 In-person Keystone Symposia Keystone, United States Keystone Resort
30th International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myelomas
Now in its 30th year, the International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies with the practical tools to translate emerging data into the best therapy for their patients, to personalize care according to patient and tumor characteristics, and to apply novel treatment strategies to improve patient outcomes. This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
26/02/2026 - 28/02/2026 In-person Physicians’ Education Resource® (PER) Miami, United States Eden Roc Miami Beach 5th How to Diagnose and Treat Acute Leukaemias
ESH How to Diagnose and Treat meetings are disease-specific meetings that address up to date diagnostic and clinical management which is greatly facilitated by and discussion of real clinical cases. Intensive interaction between the speakers and participants will be helpful in spreading knowledge. Novel and still evolving insights into the biology and diagnosis of acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease. Recently updates on prognostication and classification of acute leukaemias have been published which will be discussed in various sessions. The programme of this “How to Diagnose and Treat: Acute Leukaemias” includes genomic analysis and cutting-edge technics in routine diagnosis, targeted therapies and standard of care treatments allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes. Clonal hematopoiesis will be covered in detail. Novel trial designs instrumental for smarter drug development is discussed in a separate session.
27/02/2026 - 01/03/2026 Hybrid European School of Haematology (ESH) Mandelieu-La Napoule, France Centre Expo Congrès Mandelieu
Mediators and Moderators of Active Music Engagement (AME) to Reduce Traumatic Stress Symptoms and Improve Well-Being in Parents of Young Children with Cancer: AME as Evidence-Based Care
ASPHO webinars connect learners to the latest in Pediatric Hematology/Oncology clinical treatment, best practices, and professional development.
03/03/2026 - 03/03/2026 Virtual ASPHO (Integrative SIG) United States TBD
1st SOHO UK Meeting
The SOHO UK Annual Meeting provides expert-led sessions on diagnosis, treatment innovations, and patient management strategies in hematologic malignancies.
03/03/2026 - 04/03/2026 In-person SOHO UK London, United Kingdom Royal College of Physicians 22nd ELN & 25th KNL Symposium
The Symposium will have research sessions on the various types of leukemia and interdisciplinary specialities and plenary sessions for summary reports and keynote lectures. It will be followed by a working dinner in the foyer. Invitations will follow after the ELN Breakfast Meeting in Orlando in December 2025. Information and invitation through info@text-event.de
03/03/2026 - 03/03/2026 In-person European LeukemiaNet (ELN) & German competence network "Acute and chronic leukemias" (KNL) Mannheim, Germany Rosengarten Congress Center 9º Workshop LAL 2026: Leucemia Aguda Linfoblástica
Workshop sobre la Leucemia Aguda Linfoblástica
05/03/2026 - 05/03/2026 Hybrid PETHEMA Barcelona, Spain Hotel SB Glow
Online Course - Living Beyond Cancer: Late Effects and Survivorship Care
With around 80 % survival of childhood and adolescent cancer, around 500,000 survivors live in Europe today and the number is increasing. At least two-thirds experience long-term health-related challenges. What are the late physical and psychosocial effects? What are their risks and contributing factors? When and how to talk about them? These are the questions we will address together during the meeting by implementing different perspectives from an inter- and multidisciplinary team of late effects specialists and patient advocates across Europe.
05/03/2026 - 06/03/2026 Virtual CCI, SIOPE, Pancare Online TBD ESH 4th Translational Research Conference: Chronic Lymphocytic Leukaemia
A programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy. This translational research conference fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide. It provides opportunities for education and international networking to basic and clinical scientists, including those still in-training. A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.
05/03/2026 - 07/03/2026 In-person European School of Haematology (ESH) Stockholm, Sweden Hotel Clarion AACR Special Conference in Cancer Research: RAS Oncogenesis and Therapeutics
RAS mutations are found in about one-third of human cancers and remain a major focus of cancer research and therapy development. This meeting will highlight progress in understanding RAS biology—from biochemistry, structure, and effector signaling to new strategies that target RAS-driven cancers. Sessions will explore why colorectal cancers are less responsive to RAS inhibitors, the promise of combination approaches, and emerging resistance and immunobiology research. Bringing together leading researchers and clinicians from academia, industry, biotech, government, non-profits, and foundations, this conference will feature clinical trial updates on next-generation inhibitors and advances in genomics and liquid biopsy technologies for early detection and monitoring of RAS-driven cancers. Together, these discussions will define the current state and future directions of RAS cancer research, bridging discovery to patient impact.
05/03/2026 - 08/03/2026 In-person AACR Los Angeles, CA, United States J.W. Marriott Los Angeles L.A. Live International Extranodal Lymphoma study Group Annual Meeting 2026
The meeting aims to bring together physicians and scientists from all over the world to present and discuss the ongoing studies and to propose or plan future studies. During this Annual Meeting workshops of chairpersons and investigators of IELSG studies and pathology review sessions are organized, in order to create in-depth and open discussion about the future management of extranodal lymphomas. Participation is open to the clinicians, pathologists and scientists who have a professional interest in extranodal lymphomas. No registration fees are required, but a REGISTRATION form has to be submitted. All the relevant information on this activity will be posted on the IELSG website.
06/03/2026 - 06/03/2026 In-person International Extranodal Lymphoma Study Group (IELSG) Bellinzona, Switzerland Bellinzona Auditorium Pathology Update 2026
Pathology Update 2026 organized by RCPA
06/03/2026 - 08/03/2026 In-person RCPA Sydney, NSW, Australia TBD APOS 26
APOS 26 organized by Omico
06/03/2026 - 07/03/2026 Hybrid Omico Kensington, NSW, Australia TBD
Southern California Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
07/03/2026 - 07/03/2026 In-person Blood Cancer United Anaheim, CA, United States Marriott Cell & Gene Therapy 2026
The Cell and Gene Therapy Conference will unite industry and academic leaders to address the challenge of advancing cell and gene therapies into the clinic. Featuring insights from researchers, investors, healthcare providers, start-ups, and business developers, the event will spotlight collaborative, translational solutions.
09/03/2026 - 10/03/2026 In-person Elrig Cambridge, United Kingdom Hinxton Hall 5th Dutch ATMP Summit
The latest developments in ATMP R&D and manufacturing.
10/03/2026 - 11/03/2026 In-person Progress – Experts in Life Sciences Oegstgeest, Netherlands Corpus Leiden
2026 ESMO Sarcoma & Rare Cancers Congress
The ESMO Sarcoma and Rare Cancers Congress 2026 will once again serve as a premier forum for sharing groundbreaking research, novel treatment strategies, and fostering collaborations to drive progress in this crucial area of oncology. Join us from 12–14 March 2026 in the charming city of Lugano, Switzerland, renowned for its stunning lakeside views and rich cultural heritage. The scientific and educational programme will explore the latest advancements in diagnosis, treatment, biology, and molecular classification of rare solid tumours, ensuring a comprehensive update on the evolving landscape of these complex diseases. Attendees can engage in Abstract-related sessions, educational lectures, Multidisciplinary Tumour Boards, Special Sessions, Guidelines discussions, and dedicated Young Oncologists sessions, all designed to enhance knowledge and foster interactive discussions. Whether you are a clinician, researcher, healthcare professional, industry expert, or patient advocate, this congress offers a unique opportunity to connect, learn, and contribute to the future of sarcoma and rare cancer care. We look forward to welcoming you to Lugano for three inspiring days of scientific exchange and collaboration at the forefront of oncology.
11/03/2026 - 13/03/2026 In-person ESMO Lugano, Switzerland Palazzo dei Congressi
1st Annual Congress of the Italian Society of Liquid Biopsy
This first edition of the congress will bring together clinicians, researchers, and industry leaders to explore the latest innovations, clinical applications, and emerging challenges in liquid biopsy. Expect inspiring keynote talks, interactive sessions, and valuable networking opportunities that will help strengthen collaborations across the scientific community. Whether you’re a researcher, oncologist, biotech professional, or student, this is the place to share insights, spark collaborations, and advance the science that is transforming patient care.
11/03/2026 - 12/03/2026 In-person SIBIL Rome, Italy TBD AACR Special Conference in Cancer Research: Innovations in Kidney Cancer Research
This dynamic meeting brings together leading experts and emerging voices from around the world to explore the latest breakthroughs in kidney cancer from molecular mechanisms and tumor metabolism to immunotherapy, epigenetics, and therapeutic innovations. With a rich program of keynote lectures, plenary sessions, and abstract-driven short talks, attendees will gain cutting-edge insights and forge valuable collaborations. Whether you are a clinician, researcher, or trainee, this conference offers a unique opportunity to stay at the forefront of kidney cancer science and shape the future of cancer care.
13/03/2026 - 16/03/2026 In-person AACR Philadelphia, PA, United States W Philadelphia Tri-State Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
13/03/2026 - 13/03/2026 In-person Leukemia & Lymphoma Society New York, NY, United States Marriott Marquis
ESMO Targeted Anticancer Therapies (TAT) Congress 2026
The journey of innovation in cancer treatment begins with early drug development. ESMO TAT serves as a dynamic, multi-stakeholder forum, uniting researchers, industry leaders, investors and regulators under one roof to accelerate the delivery of life-changing anticancer therapies to patients. Join us in the pursuit to advance cancer treatment: we look forward to seeing you at this transformative event, to share new data, foster collaboration, and tackle challenges that will drive early clinical development forward. Innovate. Collaborate. Advance.
15/03/2026 - 17/03/2026 In-person ESMO Paris, France Palais des Congrès
Advanced Therapies UK 2026
The Advanced Therapies Congress is Europe's largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. The conferences brings together a community of 3,300 global executives at ExCeL London, to be inspired by 300 speakers and 75 start-ups over 2 incredible days. The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start- up companies, researchers, clinicians, academics, HTAs, payers and regulators.
16/03/2026 - 17/03/2026 In-person Terrapin London, United Kingdom TBD TROG 2026
TROG 2026 organized by TROG Cancer Research
17/03/2026 - 20/03/2026 In-person TROG Cancer Research Melbourne, VIC, Australia TBD